プログラム

198（S―46）

第2日プロ 22
グ 日 （第 1 会場：ホール A，8：20〜8：30）
ラ㈮ム

日産婦誌68巻 2 号

4 月 22 日（金）開会式

海外招聘講演 1（第 1 会場：ホール A，10：50〜11：50）
Genome editing：from modeling disease to novel therapeutics
座長：The University of Tokyo

Tomoyuki Fujii

演者：Department of Stem Cell ＆ Regenerative Biology, Harvard
University, USA

Chad Cowan

海外招聘講演 2（第 3 会場/第 4 会場：ホール B7（1）/ホール B7（2），15：30〜16：20）
Chronic Pelvic Pain：What to do when everything else fails?
座長：Osaka City University

Masayasu Koyama

演者：ALGIA Advanced Laparoscopy and Pelvic Pain Center,
Pereira, Colombia!

Juan Diego Villegas Echeverri

会長講演（第 1 会場：ホール A，13：10〜13：40）
よりやさしい低侵襲性手術を求めて
座長：広島大学

工 藤

美 樹

演者：東京医科大学

井 坂

惠 一

座長：名古屋大学

吉 川史 隆

演者：岐阜大学

森 重

健一郎

教育講演 1（第 1 会場：ホール A，8：30〜9：00）
若年がん患者の妊孕性温存

プログラム2016年 2 月

199（S―47）

教育講演 2（第 1 会場：ホール A，9：00〜9：30）
胎児心拍数モニタリング講座―胎児生理学から学ぶ―
座長：長崎大学

増 﨑

英 明

演者：福島県立医科大学

藤 森

敬 也

左 合

治 彦

!

鮫 島

浩

演者：順天堂大学

牧 野

真太郎

小 松

篤 史

仲 村

将 光

藤 田

恭 之

内 田

季 之

シンポジウム 1（第 1 会場：ホール A，15：30〜18：30）!

子宮内環境からみた胎児 well being 評価法の検討
座長：国立成育医療研究センター
宮崎大学
1）胎児心拍数レベルと時間軸を用いた胎児 well being 評価!

2）羊水量調節と胎児 well being に関する検討!

演者：東京大学3）臍帯血流動態の胎児 well being および神経学的予後に与える影響
演者：昭和大学
4）胎児大動脈脈波波形解析を用いた心・末梢循環機能評価法に関する研究
演者：九州大学
5）〈指定発言〉内診指接着型胎児オキシメーターを用いた新規胎児モニタリング法
演者：浜松医科大学

平成 27 年度学術奨励賞受賞講演（第 1 会場：ホール A，14：50〜15：30）
座長：九州大学
順天堂大学

加 藤

聖 子

竹 田

省

澤 田

健二郎

濵 西

潤 三

卵巣がんの腹膜播種の制御を目指して! !

演者：大阪大学

卵巣癌における PD 1/PD L1 経路の解明と新規治療開発
演者：京都大学

プ
ロ 22
グ日
ラ㈮
ム

プログラム200（S―48）

生涯研修プログラム 1

日産婦誌68巻 2 号!

（第 2 会場：ホール C，8：40〜9：40）

プ
ロ 22
グ日
ラ㈮
ム

がんと生殖〜がん治療後の妊娠〜
座長：埼玉医科大学

石 原

理

加 藤

友 康

河 村

和 弘

河 野

康 志

座長：九州大学

加 藤

聖 子

岡山大学

平 松

祐 司

伊 東

宏 絵

横 山

良 仁

生 水

真紀夫

村 上

節

齊 藤

英 和

杉 山

隆

国立がん研究センター中央病院
1）がん治療後の卵巣機能不全と妊娠
演者：聖マリアンナ医科大学
2）がん患者における凍結精子を用いた不妊治療の現状と妊娠予後
演者：大分大学

生涯研修プログラム 2!

（第 2 会場：ホール C，10：50〜11：50）
婦人科におけるロボット手術の現状と将来

1）婦人科ロボット手術の先進医療ならびに保険収載をめざして
演者：東京医科大学
2）ロボット支援下広汎子宮全摘術の現状
演者：弘前大学

生涯研修プログラム 3!

（第 2 会場：ホール C，14：50〜15：50）
ART 妊娠による周産期合併症〜生殖医療の立場から・周産期医療の立場から〜
座長：千葉大学
滋賀医科大学
1）生殖補助医療の現状と問題点
演者：国立成育医療研究センター
2）ART 妊娠による周産期合併症〜周産期医療の立場から〜
演者：愛媛大学

プログラム2016年 2 月

201（S―49）

生涯研修プログラム 4!

（第 2 会場：ホール C，16：20〜17：20）
骨粗鬆症 その予防と治療
座長：東京医科歯科大学

久保田

俊 郎

弘前大学

水 沼

英 樹

樋 口

毅

斎 藤

充

1）産婦人科の骨粗鬆症治療―BP 製剤，SERMs の有害事象，副効用―
演者：弘前大学
2）閉経後骨粗鬆症における骨量・骨質の低下とその治療―BP 剤と SERMs の使い分け―
演者：東京慈恵会医科大学 整形外科

ランチョンセミナー 3（第 1 会場：ホール A，12：00〜13：00）
婦人科内視鏡手術における手術環境，術野の広がりと筋弛緩の関係
共催：MSD 株式会社
座長：北海道大学

櫻 木

範 明

演者：日本大学 麻酔科

鈴 木

孝 浩

ランチョンセミナー 4（第 2 会場：ホール C，12：00〜13：00）
婦人科悪性腫瘍手術におけるコツとピットフォール
共催：ジョンソン・エンド・ジョンソン株式会社
座長：がん研有明病院

竹 島

信 宏

演者：三重県立総合医療センター

田 中

浩 彦

静岡県立静岡がんセンター

平 嶋

泰 之

ランチョンセミナー 5（第 3 会場：ホール B7（1），12：00〜13：00）
産婦人科領域における静脈血栓塞栓症予防の最近の話題〜抗凝固療法を中心に〜
共催：科研製薬株式会社
座長：順天堂大学

板 倉

敦 夫

演者：浜松医療センター

小 林

隆 夫

プ
ロ 22
グ日
ラ㈮
ム

プログラム202（S―50）

日産婦誌68巻 2 号

ランチョンセミナー 6（同時通訳付）（第 4 会場：ホール B7（2），12：00〜13：00）

プ
ロ 22
グ日
ラ㈮
ム

Curettage and Ashermanʼs Syndrome―assessment, management and risk reduction strategies―Hysteroscopic assessment and management of Ashermanʼs Syndrome―Complication of D＆C and the risk reduction strategy including use of MVA
共催：ヴォーパル・ウィメンズヘルス株式会社
座長：大阪大学

木 村正

演者：Vancouver General Hospital, Vancouver Coastal Health, The
University of British Columbia, BC Canada
Margo R. Fluker
Vancouver General Hospital, The University of British
Columbia, BC Canada

Barry H. Sanders

ランチョンセミナー 7（第 5 会場：ホール B5（1），12：00〜13：00）
婦人科領域における腹水濾過濃縮再静注法（CART）の現状
共催：旭化成メディカル株式会社
座長：埼玉医科大学国際医療センター

藤 原

恵 一

腹水濾過濃縮再静注法（CART）に求められること
演者：国立がん研究センター中央病院 乳腺・腫瘍内科
西 川

忠 曉

戸 上

真 一

卵巣がんによる難治性腹水の制御―当科における CART とベバシズマブの併用―
演者：鹿児島大学

ランチョンセミナー 8（第 6 会場：ホール B5（2），12：00〜13：00）
女性骨盤底のアンチエイジングと漢方
共催：株式会社ツムラ
座長：久留米大学

牛 嶋

公 生

演者：大阪市立大学

古 山

将 康

プログラム2016年 2 月

203（S―51）

ランチョンセミナー 9（第 7 会場：ホール D7，12：00〜13：00）
婦人科領域における悪性軟部腫瘍の治療
共催：大鵬薬品株式会社
座長：岩手医科大学

杉 山

徹

演者：東北大学病院臨床研究推進センター

高 野

忠 夫

ランチョンセミナー 10（第 8 会場：ホール D5，12：00〜13：00）
チョコレート囊胞の発癌機序と見逃さないコツ
共催：武田薬品工業株式会社
座長：熊本大学片 渕

秀 隆

演者：奈良県立医科大学

小 林

浩

ランチョンセミナー 11（第 9 会場：ホール D1，12：00〜13：00）
子宮頸がんの検査 ―新たな時代の幕開け―
共催：ホロジックジャパン株式会社
座長：慶應義塾大学

青 木

大 輔

演者：熊本大学病理診断科

三 上

芳 喜

長 阪

一 憲

東京大学

ランチョンセミナー 12（第 10 会場：G402，12：00〜13：00）
産婦人科医に知っておいて欲しい新生児管理―新生児蘇生法を中心に―
共催：アッヴィ合同会社
座長：鹿児島市立病院

茨

演者：日本大学 小児科

細 野

聡
茂 春

プ
ロ 22
グ日
ラ㈮
ム

プログラム204（S―52）

日産婦誌68巻 2 号

ランチョンセミナー 13（第 11 会場：G409，12：00〜13：00）

プ
ロ 22
グ日
ラ㈮
ム

心血管疾患リスクとしての子宮内膜症とその管理〜どのようなホルモン治療を行うべきか？〜
共催：持田製薬株式会社
座長：鳥取大学

原 田

省

演者：愛知医科大学

若 槻

明 彦

ハンズオンセミナー（第 11 会場：G409，15：30〜17：00）

共催：ヴォーパル・ウィメンズヘルス株式会社

新しい流産治療法の紹介―MVA（手動真空吸引法）って何？―
ファシリテータ：名古屋市立大学産科婦人科 不育症研究センター
尾崎

康彦，北折

珠央，松川

泰，森

亮介，杉浦

真弓

アフタヌーンセミナー 1（第 8 会場：ホール D5，16：00〜18：00）
女性ヘルスケア最前線：月経随伴症状のホルモン療法〜ライフステージに応じた治療戦略〜
共催：バイエル薬品株式会社
座長：東京大学

大須賀

穣

髙 松

潔

演者：聖路加国際病院

百 枝

幹 雄

演者：倉敷平成病院

太 田

郁 子

座長：東京大学

藤 井

知 行

演者：東京理科大学 薬学部

佐 藤

嗣 道

東京歯科大学市川総合病院!

LEP と LNG IUS の特性を生かした使い分け!

LNG IUS の効果的な使い方

イブニングセミナー 1（第 2 会場：ホール C，17：20〜17：50）
サリドマイドの催奇形性の特徴とリスク管理における留意点

プログラム2016年 2 月

205（S―53）

International Seminar（第 7 会場：ホール D7，9：50〜10：50）
Reproduction
座長：Tottori University

Tasuku Harada

National Taiwan University Hospital, Taiwan!

Hong Nerng Ho1）Reconsideration of round spermatid injection into human oocytes（ROSI）
演者：St. Mother Hospital, Japan

Atsushi Tanaka

2）MicroRNAs in Female Reproduction
演者：Gangnam Severance Hospital, Yonsei University College ofMedicine, Korea

Sihyun Cho

座長：University of Toyama

Shigeru Saito（第 7 会場：ホール D7，14：50〜15：50）
Perinatology!

Sungkyunkwan University, Korea

Suk Joo Choi

1）Physiology and pathophysiology of myometrial inflammatory reaction in parturition
演者：Hamamatsu University School of Medicine, Japan
Hiroaki Itoh2）Recent strategies and impact of a critical pathway for management of postpartum hemorrhage
演者：Yonsei University Health System, Korea

Yong Won Park（第 7 会場：ホール D7，16：20〜17：20）
Oncology
座長：Niigata University

Takayuki Enomoto

Jikei University

Aikou Okamoto

1）Optimizing Management for Patients with Advanced Ovarian Cancer
演者：Memorial Sloan Kettering Cancer Center, USA
Yukio Sonoda
2）Targeting Treatment Failure in Endometrial Cancer with Enhanced Staging：Sentinel Lymph Node!

Mapping and Infra renal Aortic Lymphadenectomy
演者：Florida Hospital Cancer Institute, University of Central
Florida College of Medicine, Orlando, Florida, USA
Robert W. Holloway（第 7 会場：ホール D7，17：20〜18：20）
Urogynecology
座長：Mackay Memorial Hospital, Taiwan
Hokkaido University!

Tsung Hsien Su
Noriaki Sakuragi1）Native Tissue Transvaginal Repair of Apical Prolapse Using Uterosacral Ligaments
演者：Baylor Scott and White Texas A＆M College of Medicine,USA

Bob L. Shull

プ
ロ 22
グ日
ラ㈮
ム

プログラム206（S―54）

日産婦誌68巻 2 号

2）Is There a Place for Mesh in Prolapse Surgery? A International Update
演者：Medical University of Vienna, Austria

Heinz Kölbl

Educational Seminarプ
ロ 22
グ 日 （第 5 会場：ホール B5（1），10：10〜10：50）
ラ ㈮ Cervical cancer prevention―HPV vaccination and screeningム
Safety and effectiveness of HPV vaccine ― global understanding and promotion
座長：Saitama Medical Center Jichi Medical University
Ryo Konno
演者：Albert Einstein College of Medicine, USA
Philip Edward Castle

医療倫理講習会!

（第 1 会場：ホール A，9：50〜10：50）
産婦人科医療における医療倫理
座長：京都大学

小 西

郁 生

演者：日本専門医機構・医療倫理・臨床研究に関する委員会/国際医療福祉大学

JSOG 婦人科腫瘍委員会

桃 井

眞里子

JSGO ガイドライン委員会共同企画（第 5 会場：ホール B5（1），14：50〜16：50）
日本産科婦人科学会婦人科腫瘍委員会婦人科悪性腫瘍登録事業データベースを用いた頸癌・体がん・卵巣がんの治療動向の推移および今後の登録事業への課題―婦人科がん治療ガイドライン導入による変化も含めて―
座長：東海大学

三 上

幹 男

熊本大学

片 渕

秀 隆

1）JSOG 腫瘍登録データを用いた子宮頸癌の治療動向・治療成績の変化―治療ガイドライン 2007 年版導入
効果の検証―
演者：東海大学
東海大学

信 田
池 田

政 子

仁 惠，他

2）JSOG 腫瘍登録データを用いた子宮体がん・卵巣がん治療動向―子宮体がん―
演者：東北大学

重 田

昌 吾

坂 口

勲

3）JSOG 腫瘍登録データを用いた子宮体がん，卵巣がん治療動向―卵巣がん―
演者：熊本大学
川崎医科大学潮 田至 央，他4）大規模人口統計データにみる米国の婦人科腫瘍に対する治療と予後の変遷
演者：南カリフォルニア大学

松 尾

高 司

山 上

亘

5）JSOG 婦人科腫瘍登録の問題点と可能性
演者：慶應義塾大学

プログラム2016年 2 月

207（S―55）

会長特別企画（第 3 会場/第 4 会場：ホール B7（1）/ホール B7（2），16：45〜18：15）
Stump the Professors〜教授陣と知恵くらべ〜
司会：京都府立医科大学
教授陣：九州大学

加 藤聖 子

浜松医科大学

金 山

尚 裕

大阪大学

木 村

正

鹿児島大学

堂 地

勉

vs

黒 星

若手軍団：大分大学

平 川

東望子

東北大学

濱 田

裕 貴

東京医科大学 寺 田

秀 昭

名古屋大学

公 博

情報交換会（表彰式含む）（ホール E（展示ホール），18：40〜21：00）

西 野

晴 夫

プ
ロ 22
グ日
ラ㈮
ム

プログラム208（S―56）

日産婦誌68巻 2 号

International Session Award Candidate
プ
ロ 22
グ日
ラ㈮
ム

第2日

4 月 22 日（金） 第 3 会場
ホール B7（1）8：30〜10：00

Group 1 Oncology 1!

Moderator：Ewha Womans University, Korea Jung Ja An
Iwate Medical University Toru Sugiyama!

IS―AC―1― 1. Casein kinase I epsilon is a novel molecular target for c Myc driven ovariancancers
Masafumi Toyoshima（Tohoku University）et al.

!

!

IS―AC―1― 2. EMT related gene Snail inhibits anti tumor immunity in ovarian cancer throughrecruitment of MDSC
Mana Taki（Kyoto University）et al.

IS―AC―1― 3. Investigation for the antineoplastic effect of lovastatin on ovarian cancer using
metabolomic analysis
Yusuke Kobayashi（Keio University）et al.

IS―AC―1― 4. Retrospective analysis on recurrent sites in 603 stage I ovarian cancer
Sou Hirose（Jikei University Kashiwa Hospital）et al.

IS―AC―1― 5. Proton pump inhibitors enhance the effects of cytotoxic agents in chemoresistantepithelial ovarian carcinoma
Eun Jin Heo（Samsung Medical Center, Sungkyunkwan University
School of Medicine, Seoul, Korea）et al.

IS―AC―1― 6. Magnetic resonance spectroscopy can be used to discriminate between benign!

endometriotic cysts and endometriosis associated ovarian cancer
Fuminori Ito（Nara Medical University）et al.

10：00〜11：45

Group 2 Oncology 2!

Moderator：Sungkyunkwan Univewrsity, Korea Duk Soo Bae
Kumamoto University Hidetaka Katabuchi
IS―AC―2― 1. Methylation analysis of DNA mismatch repair genes using DNA derived fromperipheral blood of patients with endometrial cancer：epimutation in endometrial
carcinogenesis!

Takashi Takeda（Keio University）et al.

IS―AC―2― 2. Anti tumor effect of inhibition of DNA damage response proteins, ATM and ATR,
in endometrial cancer cells
Makoto Takeuchi（The University of Tokyo）et al.

プログラム2016年 2 月

209（S―57）!

IS―AC―2― 3. An analysis of short term recurrent cases following medroxyprogesterone acetate（MPA）therapy for endometrial cancer and atypical endometrial hyperplasia
Wataru Yamagami（Keio University）et al.

!

IS―AC―2― 4. The H3K9 Methyltransferase G9a Represses E cadherin and is Associated with
Myometrial Invasion in Endometrial Cancer!

Chin Jui Wu（National Taiwan University Hospital, Taiwan）et al.

IS―AC―2― 5. Human papillomavirus（HPV）genotype is a prognostic factor of recurrence!

following loop electrosurgical excision procedure for high grade cervical!

intraepithelial neoplasia（CIN 2 3）in menopausal women
U Chul Ju（Chonnam National University Medical School, Korea）et al.

IS―AC―2― 6. Current situation of cervical cancer diagnosis, management and registration inthree national tertiary hospitals in Cambodia
Uy Kina（Khmer Soviet Friendship Hospital, Cambodia）et al.

IS―AC―2― 7. The risk estimation of gestational trophoblastic neoplasia after cytogeneticallydefined hydatidiform molar pregnancy：A prospective cohort study
Hirokazu Usui
（Chiba University）et al.

第2日

4 月 22 日（金） 第 4 会場
ホール B7（2）8：30〜10：15

Group 3 Perinatology 1
Moderator：Fu Jen Catholic University, Taiwan!

Ching Hung Hsieh

National Defense Medical College Kenichi Furuya
IS―AC―3― 1. Randomized Controlled Trial Comparing Two Different Regimes of Magnesium
Sulphate in Severe Preeclampsia：PIPES Trial
Keepanasseril A（Jawaharlal Institute of Medical Education ＆ Research,Pondicherry, India）et al.

!

!

!

IS―AC―3― 2. Hypoxia independent upregulation of placental hypoxia inducible factor 1α
contributes to the pathogenesis of preeclampsia
Takayuki Iriyama（The University of Tokyo）et al.

!

!

IS―AC―3― 3. Prediction of pre eclampsia and its severity by soluble FMS like Tyrosine Kinase
1 and Placental growth factor
Yin Yin Soe（Yangon, Central Womenʼs Hospital, Yangon, Myanmar）et al.

IS―AC―3― 4. Preeclampsia（PE）serum disrupts the autophagy/lysosome pathway cooperated
with endoplasmic reticulum（ER）stress!

Akitoshi Nakashima（University of Toyama）et al.

IS―AC―3― 5. Lower diet intake of omega 3 polyunsaturated fatty acids（PUFAs）during latepregnant is associated with late preterm birth
Aki Yamashita（The University of Tokyo）et al.

プ
ロ 22
グ日
ラ㈮
ム

プログラム210（S―58）

日産婦誌68巻 2 号!

IS―AC―3― 6. Low dose betamethasone infusions elicit partial lung maturation in a sheep modelof pregnancy
M.W Kemp（The University of Western Australia, Australia）et al.

IS―AC―3― 7. The effects of acute hypoxemia under magnesium sulphate administration on

プ
ロ 22
グ日
ラ㈮
ム

baroreflex in chronically instrumented fetal sheep
Shun Yasuda（Fukushima Medical University）et al.

10：15〜11：45

Group 4 Perinatology 2Moderator：Mackay Memorial Hospital, Taiwan!

Ming Chao Huang

Hamamatsu University School of Medicine Naohiro Kanayama
IS―AC―4― 1. Assignment of the direction and axis in single cardiac volume dataset without
information of fetal position―Toward the virtual diagnosis of fetal cardiac
lateralization disorders by 4D spatiotemporal image correlation technique!

Jin Chung Shih（National Taiwan University Hospital, Taipei, Taiwan）

IS―AC―4― 2. Fetal outcomes in pregnancies detected hypoplasia of nasal bone at second
trimester of gestation!

Tomai Xuan Hong
（University of Medicine and Pharmacy,
Hochiminh City, Vietnam）et al.

!

IS―AC―4― 3. Association analysis of polymorphisms with high risk group of gestational
diabetes mellitus in a Japanese population
Yoshifumi Kasuga（Keio University）et al.

IS―AC―4― 4. Enhanced expression of contraction associated proteins and ion channels inmyometrium of preterm mouse model with odontogenic Porphyromonas gingivalis
infection
Haruhisa Konishi（Hiroshima University）et al.

IS―AC―4― 5. Do teenagers with sexually transmitted disease during pregnancy have an
increased risk of preterm birth or chorioamnionitis?
Maggie Dwiggins（University of Illinois College of Medicine Peoria,
OSF St. Francis Medical Center, USA）et al.

IS―AC―4― 6. The differential expression of microRNA between human first trimester villous!

and extravillous trophoblast cells：PCR array based approach
Hironori Takahashi（Jichi Medical University）et al.

プログラム2016年 2 月

第2日

211（S―59）

4 月 22 日（金） 第 5 会場
ホール B5（1）8：30〜10：00

Group 5 Reproduction/Womenʼs HealthModerator：The University of Tokyo Yutaka Osuga
Nippon Medical School Toshiyuki Takeshita!

IS―AC―5― 1. Human induced pluripotent stem cells（iPS cell）differentiate to hCG producing
trophoblast（For elucidation of the various obstetrics and trophoblastic diseases）
Junya Kojima（Tokyo Medical University）et al.

IS―AC―5― 2. Exacerbation of endometriosis by dysfunction of regulatory T cells in mouse and
human

!

Yukiko Tanaka（Kyoto Prefectural University）et al.

!

IS―AC―5― 3. Identification the non obstructive azoospermia related genes in infertile maleindividuals!

Yu Ting Su（Kaohsiung Chang Gung Memorial Hospital and Chang Gung
University College of Medicine, Kaohsiung, Taiwan）et al.

IS―AC―5― 4. Clinical study of gasless Laparoscopic Adenomyosis Resection with Loop
Electrosurgical Excision Procedure（LEEP）Combined with Drug Therapy
Ping Wang（Shuguang Hospital Affiliated to Shanghai University of Chinese
Traditional Medicine, Shanghai, China）et al.

IS―AC―5― 5. Fast track gynecologic laparoscopic surgery in Korean women!

Ji Geun Yoo（The Catholic University of Korea, Korea）et al.

IS―AC―5― 6. Efficacy of self management of vaginal device for pelvic organ prolapse
Masami Hayashi（Osaka City University）et al.

プ
ロ 22
グ日
ラ㈮
ム

プログラム212（S―60）

日産婦誌68巻 2 号

International Session Mini Workshop
プ
ロ 22
グ日
ラ㈮
ム

第2日

4 月 22 日（金） 第 6 会場
ホール B5（2）9：50〜10：50

Group 1 Ovarian Cancer
Moderator：Shinshu University Tanri Shiozawa
Saitama Medical University International Medical Center Keiichi Fujiwara!

!

IS―MW―1― 1. Oncogenes（K ras and c Myc）modulate tumor immune system and enhance
peritoneal carcinomatosis in the ovarian cancer
Mitsuyo Yoshida（The University of Tokyo）et al.

IS―MW―1― 2. Combination of MDM2 inhibitor and PI3K/mTOR inhibitor showed synergistic!

anti tumor effect in ovarian clear cell carcinomas
Chinami Makii（The University of Tokyo）et al.

IS―MW―1― 3. A novel biomarker that distinguishes early stage ovarian clear celladenocarcinomas from benign endometriomas
Masae Ikeda（Tokai University）et al.

!

IS―MW―1― 4. Four pathological subtypes of high grade serous adenocarcinoma of ovary,
Fallopian tube and peritoneum indicate distinct clinical features and prognosis
Takuma Ohsuga（Kyoto University）et al.

10：50〜11：50

Group 2 Perinatology 1
Moderator：Mie University Tomoaki Ikeda
Kagawa University Toshiyuki Hata

!

!

!

IS―MW―2― 1. Branched chain amino acids regulate insulin like growth factor binding protein 1
production by decidua and influence trophoblast migration
Kei Tanaka（Kyorin University）et al.

IS―MW―2― 2. Epigenotype switch from maternal to paternal type at imprinted DMRs is
associated with placental mesenchymal dysplasia
Saori Aoki
（Kumamoto University）et al.

!

IS―MW―2― 3. Altered Notch signaling via methylation of Delta like ligand 1 in placental tissues!

with early onsetpreeclampsia
Yota Shimanuki（Juntendo University）et al.

IS―MW―2― 4. The expression of C19MC microRNAs in mesenchymal stem cells primarily
expanded from human placental tissues
Naoki Fuchi（Nagasaki University）et al.

プログラム2016年 2 月

213（S―61）

International Session Poster
第2日

4 月 22 日（金） ポスター会場①

プ
ロ 22
グ日
ラ㈮
ム

G403
13：40〜14：20

Group 1 Cervical Cancer 1
Moderator：Kagoshima University Hiroaki Kobayashi
ISP―1―

1.

Pretreatment leukocytosis predicts clinical outcome in cervical cancer
Yoshiya Miyahara（Kobe University）et al.

ISP―1―

2.

A retrospective analysis of neoadjuvant chemotherapy in the treatment of uterine
cervical cancer

ISP―1―

3.

! !

Masaaki Komatsu（Shikoku Cancer Center）et al.

!

The role of G CSF induced myeloid derived suppressor cells（MDSC）in the!

induction of cancer stem like cells in cervical cancer
Hiromasa Kuroda（Osaka University）et al.

ISP―1―

4.

HER2 as a Novel Therapeutic Target for Cervical Cancer
Eun Jin Heo（Samsung Medical Center, Sungkyunkwan

ISP―1―

5.

!

University School of Medicine, Seoul, Korea）et al.

Genome wide gene expression profiling of cervical cancer in Xinjiang women by!

!

oligonucleotide microarray and detection of apoptosis genes c IAP1, Bcl xl, Bcl2
Gulan Tuohetimulati（The Peopleʼs Hospital of Xinjiang Uyghur
Autonomous Region, China）et al.

ISP―1―

6.

Methylation of HPV16 genome CpG site in L1 and LCR are associated with HPV
persistent infection and cervical cancer development in Uyghur women
Mayinuer Niyazi（The Peopleʼs Hospital of Xinjiang Uyghur
Autonomous Region, China）et al.

ISP―1―

7.

!

Contribution of STAT3 to the resistance of TRAIL induced apoptosis in cervicalcancerHiroe Nakamura（The University of Tokyo）et al.

ISP―1―

8.

!

Regeneration of Cervical Reserve Cell like Cells from Human Induced Pluripotent
Stem Cells（iPSCs）：A Novel Method in the Field of Gynecologic Research
Masakazu Sato
（The University of Tokyo）et al.

プログラム214（S―62）

日産婦誌68巻 2 号

13：40〜14：15

Group 2 Uterine Sarcoma
Moderator：Keio University

プ
ロ 22
グ日
ラ㈮
ム

ISP―2―

1.

Nobuyuki Susumu

Mixed Endometrial Stromal and Smooth Muscle Tumors of the Uterus Associated!

with Uterine Tumor Resembling Ovarian Sex cord Tumor
Chiharu Mizoguchi（Oita University）et al.

ISP―2―

2.

Repeated resections of the tumor extend the survival of the patients withleiomyosarcoma：two case reports
Kazunari Fujino（Juntendo University）et al.

ISP―2―

3.

Pazopanib for recurrent or advanced uterine leiomyosarcoma：a case series

ISP―2―

4.

Prognostic impact of ovarian preservation and hormonal therapy in low grade

Terumi Tanigawa（Nagasaki Harbor Medical Center City Hospital）et al.

!

endometrial stromal sarcomas
Tomoko Kashiyama（The University of Tokyo）et al.

ISP―2―

5.

Efficacy of PET/CT for the differentiation of uterine sarcomas from leiomyoma

ISP―2―

6.

Uterine Leiomyosarcoma Tumorigenesis in Lmp2 deficient Mice：Involvement ofSoshi Kusunoki（Juntendo University）et al.

!

!

Impaired Anti oncogenic Factor IRF1
Takuma Hayashi（Dept. of Immunology, Shinshu University）

ISP―2―

7.

ATP7A is a promising therapeutic target for uterine leiomyosarcoma
Mamoru Kakuda（Osaka University）et al.

第2日

4 月 22 日（金） ポスター会場②
G404

13：40〜14：25

Group 3 Cervical Cancer 2
Moderator：The University of Tokyo Kei Kawana
ISP―3―

1.

Smartscopy as a new device to identify the precancerous diseases of the uterine
cervix：a pilot study
Yusuke Tanaka（Osaka University）et al.

ISP―3―

2.

Possibility of less radical treatment for patients with early invasive uterine
cervical cancer

ISP―3―

3.

!

Kim Miseon（Sapporo Medical University）et al.

Robot assisted laparoscopic radical hysterectomy：Comparison with 3D and 2D
laparoscopy；one surgeonʼs experience at Shanghai OB/GYN Hospital
Jichan Nie（Shanghai OB/GYN Hospital, Fudan University,
Shanghai, China）et al.

ISP―3―

4.

Genital bleeding during curative radiotherapy in cervical cancer
Shintaro Yanazume（Kagoshima Medical Center）et al.

プログラム2016年 2 月

ISP―3―

5.

215（S―63）

Is lympho vascular space invasion the significant risk factor for recurrence inearly cervical cancer without lymph node metastasis?
Yusuke Shimizu（Aichi Cancer Center）et al.

ISP―3―

6.

Postrecurrence oncologic outcome of patients with uterine cervical carcinoma
Kosuke Yoshida（Nagoya University）et al.

ISP―3―

7.

!

Obstetrical outcome and complications during pregnancy after fertility sparing
abdominal trachelectomy for cervical cancer
Kaoru Okugawa（Kyushu University）et al.

ISP―3―

8.

!

Treatment of early stage cervical non squamous cell carcinoma（NSCC）：clinical
significance of preoperative tumor markers and postoperative macro and/or micro
lymph node metastasis
Yuki Hirano（Tokai University Hachioji Hospital）et al.

ISP―3―

9.

Outcome of minimally invasive surgery by using sentinel lymph node biopsy incervical cancer
Asami Toki
（Tohoku University）et al.

13：40〜14：20

Group 4 Cervical Cancer 3
Moderator：Saitama Medical Center Jichi Medical University Ryo Konno!

ISP―4―1.

A Case of Lymphoepithelioma like Carcinoma in the Uterine Cervix

ISP―4―

2.

Small Cell Carcinoma of the Uterine Cervix

ISP―4―

3.

Uterine cervical adenocarcinoma metastasizing concurrently to eutopic and

Masakazu Nishida（Oita University）et al.
Satoshi Eto（Oita University）et al.

ectopic ovaries：a case report
Kaori Kiuchi（Dokkyo Medical University）et al.

ISP―4―

4.

Clinical outcomes of CIN3 after cervical conization with positive surgical margins
Tomoko Nakamoto（University of the Ryukyus）et al.

ISP―4―

5.

The retrospective analysis of the patients with positive surgical margin who
underwent the uterine cervical conization

ISP―4―

6.

!

Reiko Tasaka（Osaka City University）et al.

Surgical management for early stage cancer of the uterine cervix
Fumitaka Numa（Tokuyama Central Hospital）et al.

ISP―4―

7.

Effect of Body Mass Index（BMI）
on Treatment Outcome of Patients with Cervical
Cancer（IB1 to IVA）
Eun Jin Heo（Samsung Medical Center, Sungkyunkwan
University School of Medicine, Seoul, Korea）et al.

ISP―4―

8.

Conservative Treatment in Women with Adenocarcinoma In Situ of the Cervix
Ho Sun Choi
（Chonnam National University Medical School, Munhwa
Woman Hospital, Gwangju, Korea）et al.

プ
ロ 22
グ日
ラ㈮
ム

プログラム216（S―64）

日産婦誌68巻 2 号

13：40〜14：30

Group 5 Cervical Cancer 4
Moderator：Tokyo Womenʼs Medical University

プ
ロ 22
グ日
ラ㈮
ム

ISP―5―

1.

Yasuo Hirai!

Co testing with cytology and HPV in cervical cancer screening in Japanese
population
Yuri Sasaki（Iwate Medical University）et al.

ISP―5―

2.

Clinical outcome of atypical squamous cells of undetermined significance：aninstitutional experience
Kyoko Akashi（Kyoto Prefectural University）et al.

ISP―5―

3.

Accuracy of initial postoperative cytology and high risk HPV（HRHPV）test for
detection of recurrence of cervical intraepithelial neoplasia（CIN）after cervicallaser vaporization
Azumi Miyauchi（Keio University）et al.

ISP―5―

4.

The pathologic analysis of LSIL and ASCUS
Eunseop Song
（Inha University, Incheon, Korea）et al.

ISP―5―

5.

How do we estimate monitoring HPV infection and efficacy of HPV vaccine inJapan?

ISP―5―

6.

Yutaka Torii（Fujita Health University）et al.

!

!

HPV self sampling is effective for engaging non responders in cervical screening
and identifying cervical abnormalities
Sharon Hanley（Hokkaido University）et al.

ISP―5―

7.

Initial viral load in cases of single human papillomavirus 16 or 52 persistentinfection is associated with progression of later cytopathological findings in theuterine cervix

ISP―5―

8.

!

!

Daisuke Hamaguchi（Nagasaki University）et al.

A presence of HPV 16 or HPV 18 genotype as a reliable predictor of residual
disease in a subsequent hysterectomy after loop electrosurgical excision
procedure for cervical intraepithelial neoplasia（CIN）3
Seok Mo Kim（Chonnam National University Medical School, Korea）et al.

ISP―5―

9.

Correlation studies between HPV persistent infection, cervical cancer occurrence
and development and HPV16 L1 and LCR methylation levels
Wang Ling（Xinjiang Autonomous Peopleʼs Hospital, Xinjiang, China）et al.

ISP―5― 10.

!

Comparative Study of the effect of cervical cancer screening by Liquid Based!

Cytology and High Risk Human Papillomavirus detection in Inner Mongolia!

Xian Zhi Duan
（Beijing Tongren Hospital Affiliated toCapital Medical University 1, Beijing, China）et al.

プログラム2016年 2 月

第2日

217（S―65）

4 月 22 日（金） ポスター会場③
G405

13：40〜14：40

Group 6 Endometrial Cancer 1
Moderator：Chiba Cancer Center Naotake Tanaka
ISP―6―

1.

!

Necessity of para aortic lymphadenectomy in endometrial cancer withintermediate and high risk
Shingo Miyamoto（Showa University）et al.

ISP―6―

2.

Retrospective analysis of justification for omission of lymph node dissection inuterine endometrioid cancer stage IA（endometrioid adenocarcinoma grade 1 and
2）Yuka Asami（Showa University）et al.

ISP―6―

3.

Novel approach to predict lymph node metastatic state of uterine endometrial
cancer, toward reduction of lymphedema caused by irrelevant lymphadenectomy

ISP―6―

4.

!

Emiko Yoshida（Juntendo University）et al.

Outcomes of patients with low risk endometrial cancer surgically staged without
paraaortic lymphadenectomy based on intraoperative evaluation
Mayu Shiomi（Osaka University）et al.

ISP―6―

5.

!

Comparative study of laparoscopic surgery versus laparotomy for early stage
endometrial cancer
Reisa Kakubari（Osaka University）et al.

ISP―6―

6.

Outcome of laparoscopic surgery compared to laparotomy for early stage
endometrial carcinoma
Haruka Matsui（The University of Tokyo）et al.

ISP―6―

7.

Impact of obesity on the surgical outcomes of early stage endometrial cancer：
comparison of laparoscopic surgery and laparotomy
Yasuhiko Shiki（Osaka Rosai Hospital）et al.

ISP―6―

8.

The usefulness of hysteroscopic inspection with transcervical resection
（TCR）
for
endometrial malignancy
Kazunori Nagasaka（The University of Tokyo）et al.

ISP―6―

9.

A retrospective comparison of the safety of definitive radiotherapy in elderly and!

non elderly women with uterine cancer
Takanori Yokoyama（Hiroshima University）et al.

ISP―6― 10.

Combined large cell neuroendocrine carcinoma and endometrioid adenocarcinomaof the endometrium：A case report and survey of literature
Harunobu Matsumoto（Oita University）et al.

プ
ロ 22
グ日
ラ㈮
ム

プログラム218（S―66）

ISP―6― 11.

日産婦誌68巻 2 号

A Case Report of Combined Large Cell Neuroendocrine Carcinoma andEndometrioid Carcinoma of the Endometrium：Shared Gene Mutation Signature
between the Two Histologic Components
Masayo Ariura（Yokohama Municipal Citizenʼs Hospital）et al.

プ
ロ 22
グ日
ラ㈮
ム

ISP―6― 12.

Endometrial Metastasis from Primary Rectal Carcinoma
Satoko Yamashita（Oita University）et al.

13：40〜14：15

Group 7 Endometrial Cancer 2
Moderator：Dokkyo Medical University Kiyoshi Hasegawa
ISP―7―

1.

!

MicroRNA let 7c contributes to acquired resistance to paclitaxel in endometrial
serous carcinoma
Izumi Sato
（Tohoku University）et al.

ISP―7―

2.

!

The histone methyltransferase, SUV39H2, is a potent target of anti cancer therapy
in endometrial cancer
Kenbun Sone（The University of Tokyo）et al.

ISP―7―

3.

Development of minimum invasive endometrial cancer detection method bytargeting methylated DNA of cervical mucus
Shiho Hashimoto（Keio University）et al.

ISP―7―

4.

Mutation of any DNA mismatch repair gene can cause lower uterine segment
cancer with Lynch syndrome
Moito Iijima（Keio University）et al.

ISP―7―

5.

Significance of p53 expression in background endometrium in endometrial
carcinoma
Thithuy Nguyen（Occupational and Environmental Health University）et al.

ISP―7―

6.

Regulation of autophagy and its potential as a therapeutic target in endometrial
cancer cells

ISP―7―

7.

!

Tomohiko Fukuda（The University of Tokyo）et al.

!

Survivin inhibitor Sepantronium bromide, is a potent, novel molecular targeted
therapy against endometrial cancer
Agapiti Chuwa（The University of Tokyo）et al.

13：40〜14：10

Group 8 Endometrial Cancer 3
Moderator：Niigata University Takayuki Enomoto
ISP―8―

1.

Basic HLH type of transcriptional factors, BHLHE40 and BHLHE41 suppress!!

epithelial to mesenchymal transition of endometrial cancer cells by inhibiting SP
1 function
Kazuo Asanoma（Kyushu University）et al.

ISP―8―

2.

!

Histone methyltransferases/demethylases are novel targets of anti cancer
therapy in endometrial cancer
Shinya Oki（The University of Tokyo）et al.

プログラム2016年 2 月

ISP―8―

3.

219（S―67）

Clinical impact of DNA mismatch repair status in endometrial carcinomas
Ayumi Shikama（University of Tsukuba）et al.

ISP―8―

4.

The characteristics of LAMC1 expression patterns associated with the clinicalfeatures of endometrial cancer
Haruko Kunitomi（Keio University）et al.

ISP―8―

5.

The function of YBX2 on endometrial cancer stem cellIzumi Suzuki（Juntendo University）et al.

ISP―8―

6.

!

Isolation and characterization of cancer stem like cells from primary humanendometrioid adenocarcinoma
Yuta Tabuchi（Sapporo Medical University）et al.

第2日

4 月 22 日（金） ポスター会場④G407

13：40〜14：30

Group 9 Oncology 1
Moderator：Tohoku University Kiyoshi Ito
ISP―9―

1.

A new educational program of operative procedure with a slim and rigid
hysteroscopy
Akio Tokudome（Kagoshima University）et al.

ISP―9―

2.

Use of YouTube videos to learn laparoscopic hysterectomy

ISP―9―

3.

Dilemma in Diagnosis and Management of Huge Broad Ligament Myoma

ISP―9―

4.

What is efficient marker determining necessity of surgical hemostasis for

Koji Kumagai（Osaka Railway Hospital）et al.

!

Verlyn Zuniega Cruz（Fatima University Medical Center, Philippines）et al.

postoperative bleeding after laparoscopic surgery? Abdominal drainage volume orvital sign change?
Keisuke Murakami（Juntendo University）et al.

ISP―9―

5.

Evaluation of a new modified abdominal wall suspension system for gaslesslaparoscopic operation
Yinfeng Li（Huhhot First Hospital, Hohhot Mongolia, China）et al.

ISP―9―

6.

Introducing Curved Needles through the Homemade Glove Port in Laparoscopic
Surgery!

Li Yun Chou
（Taiwan Adventist Hospital, Taiwan）et al.

ISP―9―

7.

Development of the model for prediction of treatment response of uterine myoma
after Uterine artery embolization!

Youn Jee Chung（Seoul St. Maryʼs Hospital, College of Medicine,
The Catholic University of Korea, Seoul, Korea）et al.

ISP―9―

8.

Evaluation risk factors of uterine rupture after laparoscopic myomectomy using
MRI findings
Kohei Seo
（Showa University）et al.

プ
ロ 22
グ日
ラ㈮
ム

プログラム220（S―68）

ISP―9―

9.

日産婦誌68巻 2 号

Gynecological examination for women with severe motor and intellectual
disabilities
Hiroyuki Hashimoto（Sakai City Support Center for Severely Handicapped
Children ＆ Persons, Verde Sakai）

プ
ロ 22
グ日
ラ㈮
ム

ISP―9― 10.

Need of the surgical treatment in endometriotic cyst based on preoperative image
views
Aiko Sekine（Showa University）et al.

13：40〜14：20

Group 10 Oncology 2Moderator：Kyorin University Yoichi Kobayashi
ISP―10― 1. Three cases of gynecological malignant tumor that resulted in thrombocytopenia
during an anticoagulant therapy
Kanto Shozu（University of Toyama）et al.

ISP―10― 2. Advanced microvasive staging surgery in vaginal melanoma：A rare case reportand literature review!

!

Ngo Yeh Giin
（Chen Chi wen, Taiwan）

ISP―10― 3. Clinicopathologic characteristics of primary peritoneal carcinoma―A
retrospective analysis of single institute experience
Shoko Sakurada（Tohoku University）et al.

!

ISP―10― 4. MRI and FDG PET/CT in the clinical evaluation of patients undergoing
secondary debulking（cytoreduction）surgery for gynecologic malignancy
Yasuhiko Ebina（Kobe University）et al.

ISP―10― 5. End of life care at a general gynecology unit
Yoko Hasumi（Mitsui Memorial Hospital）et al.

!

ISP―10― 6. The retrospective study on the usefulness of re evacuation after molar pregnancy
removal surgery
Eisuke Kaneki（Kyushu University）

ISP―10― 7. Renal protective effect of magnesium sulfate in gynecologic cancer patients!

during cisplatin containing chemotherapy!

Tatsuhiro Ohgami（Kyushu University）et al.

ISP―10― 8. Short hairpin RNA library based functional screening of genes associated withhormone therapy resistance in breast cancer
Toshiyuki Okumura（Division of Gene Regulation and Signal Transduction,
Research Center for Genomic Medicine,
Saitama Medical University）et al.

プログラム2016年 2 月

221（S―69）

13：40〜14：15

Group 11 Oncology 3Moderator：Shimane University Kentaro Nakayama
ISP―11― 1. The evaluation of Surgical Management for the recurrent gynecological cancer
patients
Shu Soeda（Fukushima Medical University）et al.

ISP―11― 2. The effectiveness of the preventive education for lymphedema in the early
postoperative period for gynecological cancer patients
Noriko Kobayashi（Hokkaido University）et al.

ISP―11― 3. Toxicity profile alteration by UGT1A1 genotyping in gynecologic cancers treated!

!

with of low dose irinotecan plus platinum：a historical controlled study
Masashi Takano（National Defense Medical College Hospital）et al.

ISP―11― 4. Mental mood of gynecologic cancer patients assessed by distress and impact!

thermometer（DIT）
and hospital anxiety and depression scale（HADS）.KCOG G
1103 study
Yoshio Itani（Nara Prefecture General Medical Center）et al.

ISP―11― 5. Oncogenic BRAF promotes global DNA hypomethylation via upregulation of
DNA demethylase TET3 level
Ichiro Onoyama（Kyushu University Hospital）et al.

ISP―11― 6. EZH2 stimulates Twist expression by epigenetic silencing of its suppressor miR!

!

361 through an YY1 dependent mechanism

!

!

!

Kei Ihira（Hokkaido University）et al.

ISP―11― 7. SOCS 1 enhances T cell mediated anti tumor immunity by negative regulation of!

PD L1 and inhibits cancer proliferation
Satoshi Nakagawa（Osaka University）et al.

第2日

4 月 22 日（金） ポスター会場⑤G408

13：40〜14：30

Group 12 Ovarian Cancer 1
Moderator：Saga University Masatoshi Yokoyama!

ISP―12― 1. CX3CL1 CX3CR1 system enhances ovarian cancer progression via recruitment
CX3CR1 positive tumor associated macrophages（TAMs）!

Yuko Tanizaki（Wakayama Medical University）et al.

ISP―12― 2. ZEB1 regulates chemo resistance and metastasis in epithelial ovarian cancer
Jun Sakata（Nagoya University）et al.

プ
ロ 22
グ日
ラ㈮
ム

プログラム222（S―70）

日産婦誌68巻 2 号!

ISP―12― 3. Transferrin is involved in the carcinogenesis of high grade serous ovarian cancer!

by facilitating the DNA double strand breaks via transferrin receptor 1 infallopian tube
Shogo Shigeta（Tohoku University）et al.

プ
ロ 22
グ日
ラ㈮
ム

!

!

ISP―12― 4. Establishment of ovarian cancer patient derived xenograft
Sachiko Kitamura（Kyoto Uiversity）et al.

!!

ISP―12― 5. Significant clinical response of glypican 3 derived peptide vaccine therapy for
progressive recurrent ovarian clear cell carcinoma
Kazuto Nosaka（Nagoya University）et al.

!

ISP―12― 6. IGFBP5 derived peptide as a novel angiogenesis inhibitor for treatment of ovariancancerEun Jin Heo（Department of Obstetrics and Gynecology, Samsung Medical Center,
Sungkyunkwan University School of Medicine, Seoul, Korea）et al.

ISP―12― 7. Ethanolic and aqueous extract from Medemia argun fruitsʼ ebryo kill ovarian!

cancer cells by inducing mitochondrial dependent apoptosis and DNA damage
Mohamed Kamel Hassan（Hokkaido University）et al.

ISP―12― 8. BRCAness status of ovarian cancer with somatic large genomic rearrangements
Tomomi Ninomiya（Keio University）et al.

!

ISP―12― 9. TAS 117, a novel allosteric AKT inhibitor, shows potent antitumor activity on!

ovarian clear cell adenocarcinoma cells from fresh surgical samples in 3
dimentional culture

Kohji Tsuta（Taiho Pharmaceutical CO. LTD.）et al.

!

ISP―12― 10. Identification through a functional genomics screen of factors whose down
regulation enhances the cancer stem cell population in ovarian cancer

Koji Yamanoi（Kyoto University）et al.

13：40〜14：30

Group 13 Ovarian Cancer 2!

Moderator：Teikyo University Chiba Medical Center Liang Shan Guang
ISP―13― 1. The usefulness of ultrasonographic evaluation of malignant ovarian tumors by
IOTA（International Ovarian Tumor Analysis）study
Kanae Shimada（Showa University）et al.

ISP―13― 2. Attempt of preoperative risk estimation of ovarian malignancy by ultrasound：
Using 3D ultrasound and IOTA study
Tsuneo Inoue（Nagasaki University）et al.

ISP―13― 3. A comparative analysis of diagnostic performance to detect ovarian malignancy
among three assessment indices
Hidenori Machino（The University of Tokyo）et al.

プログラム2016年 2 月

223（S―71）

ISP―13― 4. Prognostic significance of the Recurrence pattern and Risk factors for survival in
ovarian cancer patients with No gross residual disease after Primary Debulking
Surgery
E Sun Paik
（Samsung Medical Center, Sungkyunkwan
University School of Medicine, Seoul, Korea）et al.

ISP―13― 5. Accuracy of ROMA（Risk of Ovarian Malignancy Algorithm）in Predicting!

Malignancy of Ovarian Tumours for Pre menopausal Women
Win Win Mya（Central Womenʼs Hospital and University of Medicine（1）,Yangon, Union of Myanmar）et al.

ISP―13― 6. Incidence and risk factors of lower extremity lymphedema after gynecologicalsurgery in ovarian cancer
Jong Sup Park
（The Catholic University of Korea, Seoul
St. Maryʼs Hospital, Korea）et al.

ISP―13― 7. Clinical study of immature teratoma
Akihito Yamamoto（Nippon Medical School）et al.

ISP―13― 8. Chemotherapeutic Retroconversion of Immature Teratoma of the Left Ovary with
Subsequent Occurrence of Mature Teratoma in the Uterus：A Case Report
Carlomer Tan Camanong（St. Lukeʼs Medical Center, Quezon City, Philippines）

ISP―13― 9. Ovarian Serous borderline tumor：Clinicopathologic analysis of 103 cases
Ryusuke Kaya（Jikei University）et al.

ISP―13― 10. Malignant transformation of mucinous borderline tumor long after primarylaparoscopic surgery
Satoshi Tamauchi（Nagoya University Hospital）et al.

13：40〜14：20

Group 14 Ovarian Cancer 3
Moderator：Kanazawa Medical University

Toshiyuki Sasagawa

ISP―14― 1. Pulmonary type of small cell carcinoma of the ovary：a case report
Masaru Kawanishi（Osaka City University）et al.

ISP―14― 2. Mitotically active cellular fibroma of the ovary：a case report and literature
review
Takashi Yamada（Osaka Medical College）et al.

ISP―14― 3. Primary Papillary Serous Cystadenocarcinoma of the ovary complicated by
Neoplastic pericardial effusion：A case report
Gleen Rose O. Aguilar（Fatima University Medical Center, Philippines）et al.

ISP―14― 4. Chemotherapy in patients with recurrent or persistent clear cell carcinomas
Kayoko Takahashi（Dokkyo Medical University）et al.

ISP―14― 5. Survival analysis of revised 2014 FIGO staging classification of epithelial ovariancancer and comparison with previous FIGO staging classification
Kaho Suzuki（Kobe University）et al.

プ
ロ 22
グ日
ラ㈮
ム

プログラム224（S―72）

日産婦誌68巻 2 号

ISP―14― 6. Recurrence pattern in 80 cases of stage III/IV ovarian carcinomas with complete
intraperitoneal cytoreduction
Tomoki Tanaka（The University of Tokyo）et al.

!

!

ISP―14― 7. Outcomes of laparoscopic fertility sparing surgery in presumed early stage

プ
ロ 22
グ日
ラ㈮
ム

epithelial ovarian cancer
Eun Jin Heo（Samsung Medical Center, Sungkyunkwan
University School of Medicine, Seoul, Korea）et al.

ISP―14― 8. Comparison of two groups diagnosed recurrence by different initial diagnostic
method in recurrent epithelial ovarian cancer patients with secondary
cytoreductive surgery
E Sun Paik
（Samsung Medical Center, Sungkyunkwan
University School of Medicine, Seoul, Korea）et al.

第2日

4 月 22 日（金） ポスター会場⑥
G410

13：40〜14：35

Group 15 Ovarian Cancer 4
Moderator：University of Tsukuba

Toyomi SatohISP―15― 1. Expression of VEGF in ovarian cancer suppresses tumor immunity via
recruitment of myeloid derived suppressor cells（MDSC）!

Naoki Horikawa（Kyoto University）et al.

ISP―15― 2. SIRT1 increases proliferation, chemo resistance and invasiveness of ovariancarcinoma cells
David Mvunta（Shinshu University）et al.

ISP―15― 3. Cancer cell and oncogene alter subset populations of T and dendritic cells in thetumor microenvironment of disseminated ovarian cancer model
Juri Takahashi（The University of Tokyo）et al.

ISP―15― 4. LATS1 phosphorylation at serine 909 by Gα13 is involved in YAP activation in
ovarian cancer cells
Hiroshi Yagi（Kyushu University）et al.

!

ISP―15― 5. Global cancer related microRNA expression analysis in epithelial ovarian cancer
Yukiko Noguchi（The Jikei University）et al.

ISP―15― 6. Can gynecologic oncologist counsel effectively BRCA genetic test and counselingamong advanced ovarian carcinoma
Min Kyu Kim（Samsung Changwon Hospital,!

Sungkyunkwan University of Medicine, Korea）et al.

ISP―15― 7. Anti LSR monoclonal antibody inhibits ovarian cancer growth via inhibition oflipid metabolism
Kosuke Hiramatsu（Itami City Hospital）et al.

プログラム2016年 2 月

225（S―73）

ISP―15― 8. CDX2 regulates Multidrug Resistance 1 expression in ovarian mucinous
adenocarcinoma
Iemasa Koh（Hiroshima University）et al.

!

ISP―15― 9. Interleukin 6 Expression and its Relationship with Clinicopathological Features
including ARID1A Expression in Stage I Clear Cell Carcinoma of the Ovary
Ayako Kawabata（The Jikei University）et al.

!

ISP―15― 10. Elevated level of circulating microRNA 99a correlates with serous epithelial
ovarian cancer and can be used as a potential biomarker
Akihiko Yoshimura（Osaka University）et al.

!

ISP―15― 11. PAI 1（plasmin activator inhibitor 1）as a therapeutic target for ovarian cancer
Erika Nakatsuka（Osaka University）et al.

13：40〜14：25

Group 16 Ovarian Cancer 5
Moderator：St. Marianna University Nao Suzuki
ISP―16― 1. Prediction of taxane and platinum chemosensitivity in ovarian cancer based ongene expression profiles!

Ryusuke Murakami（Kyoto University）et al.

!

!

ISP―16― 2. Three combined treatment, a HDAC inhibitor OBP 801/YM753, paclitaxel and 5!

fluorouracil induces G2 phase arrest in human ovarian cancer cells
Makoto Akiyama（Kyoto Prefectural University）et al.

!

ISP―16― 3. Number of somatic mutations by whole exome sequencing is associated with both!

surgical outcome and chemosensitivity in high grade ovarian serous carcinoma
Kayo Asada（The University of Tokyo）et al.

!

ISP―16― 4. Doxorubicin hydrochloride and Bevacizumab for the patients with Platinum
taxane resistant ovarian cancer

Tsuyoshi Ota（Juntendo University）et al.

ISP―16― 5. Bevacizumab in ovarian cancer：its safety and effectivenessHyangsang Lee（Osaka University）et al.

ISP―16― 6. Side effects of bevacizumab in epithelial ovarian cancer
Rieko Kawase（Nippon Medical School）et al.

ISP―16― 7. Our experience of bevacizumab in the chemotherapy of ovarian cancer
Takafumi Ujihira（Juntendo University）et al.

ISP―16― 8. A study on the efficacy of bevacizumab（BEV）for advanced and recurrent ovariancancerKiyoshi Aiko（Kyushu University）et al.

ISP―16― 9. The experience of the treatment of the epithelial ovarian cancer with
bevacizumab
Takuma Wada
（Osaka City University）et al.

プ
ロ 22
グ日
ラ㈮
ム

プログラム226（S―74）

第2日

日産婦誌68巻 2 号

4 月 22 日（金） ポスター会場⑦
G502

プ
ロ 22
グ日
ラ㈮
ム

13：40〜14：35

Group 17 Perinatal Care 1
Moderator：Chiba University Hisao Osada
ISP―17― 1. Clinical features of obstetrical antiphospholipid syndrome in the Japanese
population―A multicenter study
Masashi Deguchi（Kobe University）et al.

ISP―17― 2. Retrospective analysis of the perinatal outcomes of 191 cases who were treatedwith the combination therapy of low dose aspirin and heparin
Ryo Yokomizo（The Jikei University）et al.

ISP―17― 3. Th1/Th2 immune polarity induced by invariant NK cell stimulation determines
the incidence of mouse miscarriage
Mari Hoya（The University of Tokyo）et al.

ISP―17― 4. How do the women feel after having NIPT? A year later survey among 3000
women
Junko Yotsumoto（Ochanomizu Univesity）et al.

ISP―17― 5. Noninvasive Prenatal Screening and its Relevance to Clinical Practice：Update on
Clinical Outcome Metrics on Over 85,000 Cases
Holly Snyder（Illumina, Redwood City, CA, USA）et al.

!

ISP―17― 6. Uniparental disomy analysis in trios using genome wide SNP array and whole!

genome sequencing data imply the segmental uniparental isodisomy in general
populations
Kiyonori Miura（Nagasaki University）et al.

ISP―17― 7. Monitoring of intrinsic optical signals relating to cerebral hemodynamics andcellular morphology in a rat hypoxic ischemic encephalopathy model
Sakiko Kinoshita（The University of Tokyo）et al.

ISP―17― 8. Prenatal diagnosis of urorectal septum malformation sequence with thedescription of new variant. Insight into the embryogenesis!

Kuan Ying Huang（National Taiwan University Hospital andNational Taiwan University College of Medicine, Taipei, Taiwan）et al.

ISP―17― 9. Omphalopagus―A Rare Case Report
Nahar N
（N/A, Bangladesh）et al.

ISP―17― 10. Conditioned medium from human amniotic fluid stem cell ameliorated glutamate!

induced apoptosis
Marie Fukutake（Keio University）et al.

ISP―17― 11. Does the oxytocin during induced labor directly increase the risk of autism?
Takashi Hirayama（Juntendo University）et al.

プログラム2016年 2 月

227（S―75）

13：40〜14：30

Group 18 Fetal Complication 1
Moderator：Miyagi Childrenʼs Hospital Jun Murotsuki!

ISP―18― 1. Changes of time interval in the ventricular inflow patterns in fetal growth
restriction
Yasushi Kurihara（Osaka City University）et al.

ISP―18― 2. Myocardial diastolic function with early diastolic intraventricular pressure
difference in fetuses
Yuka Yamamoto（Juntendo University）et al.

ISP―18― 3. HDlive silhouette mode in diagnosis of fetal jejunal atresia
Masato Mashima（Kagawa University）et al.

ISP―18― 4. Perinatal diagnosis and outcome of fetal skeletal dysplasia：a report of 8 cases
Mari Kawamata（Kyoto Prefectural University）et al.

ISP―18― 5. Sirenomelia associated with an abdominal cyst and a single umbilical artery
Yui Kinjo（Ryukyu University）et al.

ISP―18― 6. The survey of thrombocytopenia in newborn baby
Takahiro Yamashita（Aiiku Hospital）et al.

!

ISP―18― 7. Prenatal demonstration of distal right coronary artery in normal and growth
restricted fetuses

Susumu Miyashita（Dokkyo Medical University）et al.

ISP―18― 8. In utero stem cell therapy for Osteogenesis Imperfecta：a clinical case report!

!

Masayuki Endo（Osaka University）et al.

ISP―18― 9. A case of X linked VACTERL H association with FANCB mutation
Norikazu Watanabe（Yamagata University）et al.

!

ISP―18― 10. HDliveFlow with HDlive silhouette/glass body rendering mode of the fetal heart
Megumi Ito（Kagawa University）et al.

13：40〜14：25

Group 19 Threatened Abortion
Moderator：Nagoya City University Mayumi Sugiura
ISP―19― 1. Prevention of Preterm Labor by ω3 Polyunsaturated Fatty Acids（PUFAs）
Eri Inoue（The University of Tokyo）et al.

ISP―19― 2. Iron supplementation is ineffective for anemia triggered by ritodrinehydrochloride administration in women with threatened preterm labor
Hiroshi Koike（The University of Tokyo）et al.

!

ISP―19― 3. Appropriate antibiotic therapy for preterm labor with or without intra amniotic!

microbes evaluated by rapid and false positive negative PCR system could
prolong gestational period
Satoshi Yoneda（University of Toyama）et al.

プ
ロ 22
グ日
ラ㈮
ム

プログラム228（S―76）

日産婦誌68巻 2 号

ISP―19― 4. The effects for administration of preterm labor with protocol alteration intocolytic agents
Masamitsu Nakamura（Showa University）et al.

ISP―19― 5. Effect of progesterone on human cervical fibroblast―from basic research to

プ
ロ 22
グ日
ラ㈮
ム

clinical significanceYoshimitsu Kuwabara（Nippon Medical School）et al.

ISP―19― 6. Laparoscopic Cervicoisthmic Cerclage to Prevent Preterm Birth in Second
Trimester!

Ya Min Cheng（National Cheng Kung University Hospital, Collegeof Medicine, National Cheng Kung University, Tainan, Taiwan）

ISP―19― 7. Comparison Between Nitroglycerin Dermal Patch And Nifedipine For Treatment
Of Preterm Labor, a randomized clinical trial
Maryam Kashanian（Iran University of Medical Sciences, Iran）et al.

ISP―19― 8. The effect of prophylactic cervical cerclage in triplet pregnancies
Moe Yorozu（Okayama Medical Center）et al.

ISP―19― 9. Cervical SLPI expression during pregnancy is regulated by progesterone in mouse
Taiki Samejima（The University of Tokyo）et al.

13：40〜14：30

Group 20 PIH
Moderator：Saitama Medical Center Hiroyuki Seki
ISP―20― 1. Management of severe hypertension by nicardipine IV drip in pregnancyinduced
hypertension after cesarean section
Tomoe Nakagawa（Nagoya City Medical Center）et al.

ISP―20― 2. Acute Pulmonary Edema in Preeclampsia and Gestational Hypertension：a!

Single center Retrospective Study
Naoko Fukuda（Metropolitan Bokutoh Hospital）et al.

ISP―20― 3. Magnesium sulfate may ameliorate oxidative stress and inflammation inpreeclampsia
Kaoru Kawasaki（Kyoto University）et al.

ISP―20― 4. Serial findings of cerebral imaging together with changes in blood pressure andbiological marker in eclampsia
Ayano Matsuura（Nagoya City Medical Center）et al.

ISP―20― 5. A case of subarachnoid hemorrhage under the optimal blood pressure control after
eclampsia without pregnancy induced hypertension
Naoki Matsuoka（Chugoku Rosai Hospital）et al.

ISP―20― 6. A case of hepatic infarction as a result of HELLP syndrome
Rena Ishikawa（Yokohama City University Hospital）et al.

ISP―20― 7. ER stress regulates PlGF transcription and potential therapeutic strategy for pre!

eclampsia
Masahiro Suzuki（Sapporo Medical University）et al.

プログラム2016年 2 月

229（S―77）!

ISP―20― 8. Circulating levels of C19MC cluster microRNAs in pregnant women with severe
preeclampsia
Ai Higashijima（Nagasaki University）et al.

ISP―20― 9. Novel inflammatory markers of adipose tissue in the normal pregnancy andpreeclampsia：New strategy into understanding of pathophysiology of the disease
Katsuhiko Naruse（Nara Medical University）et al.

!

!

ISP―20― 10. Effects of omega 3 fatty acids on Nod like receptor 3（NLRP3）inflammasome indecidual macrophages
Fusako Sue（The University of Tokyo）et al.

第2日

4 月 22 日（金） ポスター会場⑧G507

13：40〜14：20

Group 21 Perinatal Care 2
Moderator：Nagara Medical Center

Ichiro Kawabata!

ISP―21― 1. Breast feeding in complex disaster：results from the Fukushima HealthManagement Survey
Hyo Kyozuka（Fukushima Medical University）et al.

ISP―21― 2. Emergency preparedness on Maternal and Child health System with ALSO/BLSO―Lessons learned in the Great East Japan Earthquake Affected Areas
Honami Yoshida（National Institute of Public Health）et al.

ISP―21― 3. The Optimal Period for the Deliveries of Diamniotic Dichorionic Twin
Pregnancies with Selective Fetal Growth Restriction
Masanao Ohashi（Miyazaki University Faculty of Medicine）et al.

ISP―21― 4. Interlocking of twins may cause malpresentation and malrotation of the vertex
first twin；Four case reports of failed trial of labor
Akihiko Ueda（Kurashiki Central Hospital）et al.

ISP―21― 5. Retrospective analysis of 27 cases transported from local clinic due to massive
postpartum hemorrhage
Shuichiro Endo（Juntendo University Urayasu Hospital）et al.

!

ISP―21― 6. Transcatheter arterial embolization as first line rescue in intractable primary
postpartum hemorrhage：assessment, outcome, and subsequent fertility!

Hsin Hsin Cheng（Kaohsiung Chang Gung Memorial Hospital andChang Gung University College of Medicine, Kaohsiung, Taiwan）et al.

ISP―21― 7. To assess cervical dilatation and position of fetal head during labor using wirelessmobile ultrasound device
Kim Ju Young（Gil Hospital, College of Medicine,
Gachon University, Incheon, Korea）et al.

プ
ロ 22
グ日
ラ㈮
ム

プログラム230（S―78）

日産婦誌68巻 2 号

ISP―21― 8. Consecutive change of cervical length in placenta previa for the prediction of
emergent cesarean delivery
Sa Jin Kim（Holy Family Hospital of Catholic University, Kyungido, Korea）et al.

13：40〜14：20

プ
ロ 22
グ日
ラ㈮
ム

Group 22 Fetal Complication 2
Moderator：Teikyo University Eiji Ryo!

ISP―22― 1. Relationship between serum D dimer levels and placental findings in pregnant
women with fetal growth restriction
Norifumi Tanaka（Hiroshima University）et al.

ISP―22― 2. Nuchal cord complication combined with small for gestational age increases therisk of fetal distress during labor
Liangcheng Wang
（Warabi City Hospital）et al.

!

ISP―22― 3. HDlive in assessment of fetal intrathoracic and intra abdominal anomalies
Nobuhiro Mori（Kagawa University School of Medicine）et al.

ISP―22― 4. Retrospective study on the association of underlying causes of polyhydramnios
with fetal growth
Chisato Kunitomi（The University of Tokyo）et al.

!

ISP―22― 5. Can fetal electrocardiograph find high risk fetal mice of brain hemorrhage?
Takuya Ito（Tohoku University）et al.

ISP―22― 6. Prenatal resolution of microcystic congenital cystic adenomatoid malformation（CCAM）：a report of two cases with different initial CVR（CCAM volume ratio）
Satoe Kirino（Okayama Medical Center）et al.

ISP―22― 7. Effect of ethnicity on fetal behavior：comparison of Asian and Caucasian
populations
Mohamed Aboellail（Kagawa University）et al.

ISP―22― 8. The study of murine short term variability at each fetal stage
Takahiro Minato（Tohoku University）et al.

第2日

4 月 22 日（金） ポスター会場⑨G508

13：40〜14：20

Group 23 Maternal Complication 1
Moderator：Tokyo Womanʼs Medical University Yachiyo Medical Center Naoki Masaoka
ISP―23― 1. Vaginal inflammatory preconditioning triggers fetal brain inflammation which
contributes to block acute fetal death in response to amniotic LPS
Yupeng Dong
（Advanced Interdisciplinary Biomedical Engineering,Tohoku University）et al.

プログラム2016年 2 月

231（S―79）

ISP―23― 2. The effect of maternal screening for HBV and perinatal HBV prevention program
Yuki Sasagawa（Kobe University）et al.

ISP―23― 3. Maternal blood screening for congenital cytomegalovirus infection of the infants
Shinya Tairaku（Kobe University）et al.

ISP―23― 4. A case of fetal cytomegalovirus infection in which maternal IgM antibodies wereabsentMinoru Kawakami（Kyushu University）et al.

ISP―23― 5. Malignant tumor in pregnancy：A clinical study of 22 patients
Momoko Inoue（Jikei University）et al.

ISP―23― 6. Adenocarcinoma Located in Pancreatic Tail During Pregnancy：A Case Reportand Literature Review
Yuma Goto（University of Miyazaki）et al.

!

ISP―23― 7. Factors associated with depressive symptoms during mid pregnancy at aJapanese University Hospital
Hideto Shimada（Tokyo Medical University）et al.

!

ISP―23― 8. A case of successful live birth in a woman on long term hemodialysis
Yurie Nakamura（Kyushu University）et al.

13：40〜14：15

Group 24 Abnormal delivery
Moderator：Keio university

Kei Miyakoshi

ISP―24― 1. Impact of a history of myomectomy on cesarean section!

Asuka Yoshiara（The University of Tokyo）et al.

ISP―24― 2. Comparative analysis of 15 years ago and the current cesarean delivery rates!

using 10 group classification
Takao Owa
（Osaka University）et al.

ISP―24― 3. Risk factors for birth canal trauma with forceps delivery
Yasuko Sano（Juntendo University）et al.

ISP―24― 4. Safety and reliability of forceps delivery based on novel fetal head evaluation：
Analysis of 1532 cases
Masaya Takahashi（Saitama Medical Center）et al.

ISP―24― 5. Vaginal versus Cesarean Breech Delivery：Maternal and Neonatal Outcome at!

Bulacan Medical Center, A Two Year Retrospective Study
Jerica Miah DS. Borgonia（Bulacan Medical Center, Philippines）et al.

ISP―24― 6. Cervical varix complicated by placenta previa：a case presentation and literature
review
Mie Tanaka（Osaka University）et al.

ISP―24― 7. Rule out the adherent placenta：evaluation with magnetic resonance imaging
Aiko Okada（Osaka University）et al.

プ
ロ 22
グ日
ラ㈮
ム

プログラム232（S―80）

第2日

日産婦誌68巻 2 号

4 月 22 日（金） ポスター会場⑩
G509

プ
ロ 22
グ日
ラ㈮
ム

13：40〜14：30

Group 25 Nutrition and Metabolism
Moderator：Ehime University Takashi Sugiyama
ISP―25― 1. Increased expression of SOCS3 may contribute to decreased expression of TNF
alpha in the placenta of gestational diabetes mellitus
Eiji Shibata（University of Occupational and Environmental Health）et al.

ISP―25― 2. The BMI before pregnancy and vaginal microbiota involved in the development of
GDM
Seishi Furukawa（Kyorin University）et al.

ISP―25― 3. Estimating the risk of gestational diabetes in women who are positive for 50g
glucose challenge test：Development of the prediction model based on patientcharacteristics!

Jae Yoon Shim
（University of Ulsan College of Medicine, Asan
Medical Center, Seoul, Korea）et al.

!

ISP―25― 4. Weight gain during pregnancy and risk of late onset gestational diabetes
Dittakarn Boriboonhirunsarn（Faculty of Medicine Siriraj Hospital,
Mahidol University, Bangkok, Thailand）

ISP―25― 5. Postpartum screening for glucose intolerance in women with gestational diabetes
mellitus
Nobue Kojima（Kobe University）et al.

ISP―25― 6. Does low result of one hour 50g glucose challenge test predict adverse fetal andmaternal outcomes?
Nozomi Owada（Yokohama City University）et al.

ISP―25― 7. In early gestation, maternal smoking leads to increased epigenetic alterations at
the promoters of nitrogen compound metabolic and transcriptional regulators
Akihiro Kawashima（Showa University）et al.

ISP―25― 8. Maternal hemoglobin level might correlate with the fetal hemoglobin level
Yoko Gekka（Aiiku Hospital）et al.

ISP―25― 9. The progression of anemia during pregnancy correlates with the mothersʼ
insufficient weight gain during pregnancy
Hirotaka Nishida（Aiiku Hospital）et al.

ISP―25― 10. Distribution of core temperature under maternal abdominal wall during
pregnancy
Yoshitaka Kimura（Advanced Interdisciplinary Biomedical Engineering,Tohoku University）et al.

プログラム2016年 2 月

第2日

233（S―81）

4 月 22 日（金） ポスター会場⑪G510

13：40〜14：20

Group 26 Maternal Complication 2
Moderator：Shiga University of Medical Science

Kentaro Takahashi!

ISP―26― 1. Normal ranges of plasma concentrations of pregnancy associated microRNAs
during pregnancy
Yuko Murakami（Nagasaki University）et al.

ISP―26― 2. Issues for the management of pregnancy of the women with adult congenital heartdiseaseHironobu Hyodo（Tokyo Metropolitan Bokutoh Hospital）et al.

ISP―26― 3. Successful pregnancy in a woman complicated Stage 4 extracranial arteriovenous
malformation with amputated one leg
Mitsuyasu Yamada（Osaka University）et al.

ISP―26― 4. Inferior vena cava filter for deep vein thrombosis in early pregnancy：a report ofthree cases
Yohei Onodera（Akita University）et al.

ISP―26― 5. Pregnant women with inherited thrombocytopenia
Yukie Kidani（Hiroshima University）et al.

ISP―26― 6. To assess the management of pregnancies complicated with antithrombin
deficiency：A report of 20 cases
Kana Deguchi（Kobe University）et al.

ISP―26― 7. Short umbilical cord length reflective of adverse pregnancy outcomes in a
Japanese population
Yuriko Yamamoto（Yokohama City University Medical Center）et al.

ISP―26― 8. Asymptomatic pyuria in pregnant women during the first trimester is associatedwith an increased risk of adverse obstetrical outcomes!

Yun Ju Lai（Chang Gung Memorial Hospital, Kaohsiung, Taiwan）et al.

13：40〜14：25

Group 27 Maternal Complication 3
Moderator：Tokyo Medical and Dental University Naoyuki Miyasaka!

ISP―27― 1. Pregnancy after uterine artery embolization for the treatment of post partum
hemorrhage：a case series
Mayumi Morizane（Kobe University）et al.

ISP―27― 2. Pregnancy after laparoscopic myomectomy!

Jun Takeda（Juntendo University）et al.

ISP―27― 3. Pregnancy related cystic ovarian tumor―A case report
Yu Ito（Osaka University）et al.

プ
ロ 22
グ日
ラ㈮
ム

プログラム234（S―82）

日産婦誌68巻 2 号!

ISP―27― 4. 3D HD flow with HDlive silhouette mode in diagnosis of uterine artery
pseudoaneurysm during pregnancy
Kenta Yamamoto（Kagawa University）et al.

ISP―27― 5. Obstetric outcome after laparoscopic removal of rudimentary horn

プ
ロ 22
グ日
ラ㈮
ム

Masaaki Sawada（Osaka University）et al.

ISP―27― 6. Rupture of a Bicornuate Uterus in a Primigravida with No Other Risk Factors
Maggie Dwiggins（University of Illinois College of Medicine Peoria,
OSF St. Francis Medical Center, USA）et al.

ISP―27― 7. Severe and Short Dizziness in a Pregnant Woman with Type I Arnold Chiari
Malformation：A case report and review of the literature
Masanori Ono（Saitama City Hospital）et al.

ISP―27― 8. Pregnancy outcomes after liver transplantation
Naoko Terawaki（Hiroshima University）et al.

ISP―27― 9. Effect of bed rest during pregnancy on thicknesses of quadriceps femoris muscle
in pregnant and postpartum women
Yohei Takahashi（Tokushima University）et al.

13：40〜14：30

Group 28 Technique
Moderator：Hamamatsu University School of Medicine Motoi Sugimura
ISP―28― 1. Laparoscopic conservative treatment of an intramural ectopic pregnancy after
abdominal myomectomy：a case report
Masafumi Katakura（Toho University Omori Medical Center）et al.

ISP―28― 2. Perioperative complications after uterine compression sutures
Yosuke Suzuki（Osaka University）et al.

ISP―28― 3. Vascular complications of temporary balloon occlusion of the common iliac arteryfor bleeding control during surgery of placenta accreta：what will be our next
step?

!

Tu Yi An
（National Taiwan University Hospital, Taipei, Taiwan）et al.

ISP―28― 4. Risk stratification score for the prediction of surgical site infections with cesareandeliveryNatasha Patel（University at Buffalo, State University of New York, USA）et al.

!

ISP―28― 5. Adverse Events after Non obstetric Surgery in Patients with Pregnancy：A
Nationwide Study!

Chien Chang Liao（School of Medicine, Taipei Medical
University, Taipei, Taiwan）et al.

ISP―28― 6. Efficacy of a 40 mg single intravenous Parecoxib for postoperative pain control
after elective cesarean delivery：a double blind randomized controlled trial
Tripop Lertbunnaphong（Faculty of Medicine Siriraj Hospital,
Mahidol University, Bangkok, Thailand）et al.

プログラム2016年 2 月

235（S―83）

ISP―28― 7. Tranexamic acid for prevention of postpartum haemorrhage in cesarean section：!

A meta analysis
Andrew Putranagara（St. Martin de Porres Charity Hospital, Philippines）et al.

ISP―28― 8. Evaluation of hypogastric artery ligation as a lifesaving method of controlling
pelvic hemorrhage in obstetrics and gynecology
Priyadarshini Tiwari（NSCB Medical College, Jabalpur, India）et al.

ISP―28― 9. Bakri balloon tamponade for reducing blood loss during delivery and postpartumof patients with placenta previa
Hidenori Sasa（National Defense Medical College）et al.

ISP―28― 10. Quantified Blood Loss：An Alternative Method in correlating change in pre!

!

delivery and post delivery hematocrit
Caitlin Dunham（Florida State University College, USA）et al.

13：40〜14：30

Group 29 Placenta
Moderator：Niigata University Koichi Takakuwa
ISP―29― 1. The expression of fibrosis related factor in villous stroma of placenta complicatedwith preeclampsia is induced by hypoxia and TGFβ stimulation
Takako Ohmaru（Kyushu University）et al.

ISP―29― 2. Enhanced expression of lysophosphatidic acid receptors in preeclamptic placentas
Tatsuya Fujii（The University of Tokyo）et al.

ISP―29― 3. Cytokine levels in serum, placenta and amniotic membrane of the preterm mousemodel with chronic odontogenic porphyomonas gingivalis infection
Yuko Teraoka（Hiroshima University）et al.

!

ISP―29― 4. Risk factors for retained products of conception after mid trimester abortion
Tomoko Noguchi（Wakayama Medical University）et al.

!

ISP―29― 5. Decreased expression of indoleamine 2, 3 dioxygenase in placenta withpreeclampsia and/or fetal growth restriction
Naoyuki Iwahashi（Wakayama Medical University）et al.

ISP―29― 6. Gene expression profiling in the process of human cytotrophoblast differentiation
into syncytiotrophoblast
Kazuki Morita（The University of Tokyo）et al.

ISP―29― 7. Transcriptome profiling of purified human trophoblast cells
Hirotaka Hamada（Tohoku University Hospital）et al.

ISP―29― 8. The investigation of placental carucium transport system
Toshihide Sakuragi（University of Occupational Environmental Health）et al.

ISP―29― 9. Sonic hedgehog pathway may play an important role in placental function
Hiroshi Takai（Kyoto University Graduate School of Medicine）et al.

!

ISP―29― 10. Circulating levels of C19MC cluster microRNAs in pregnant women withabruptio placenta
Yuri Hasegawa（Nagasaki University）et al.

プ
ロ 22
グ日
ラ㈮
ム

プログラム236（S―84）

第2日

日産婦誌68巻 2 号

4 月 22 日（金） ポスター会場⑫
セミナー室（1）

プ
ロ 22
グ日
ラ㈮
ム

13：40〜14：05

Group 30 ART
Moderator：Sugiyama Clinic

Koji Nakagawa

ISP―30― 1. Endoplasmic reticulum（ER）stress induces vascular endothelial growth factor（VEGF）production in granulosa cells：implications for a novel therapeutic
approach for OHSS
Nozomi Takahashi（The University of Tokyo）et al.

ISP―30― 2. Fertilization of dysmorphic human oocytes and subsequent embryo development
Eun Jeong Yu（Seoul National University Hospital, Seoul, South Korea）et al.

ISP―30― 3. Assisted Reproductive Technology（ART）in Japan 2013. Annual report of JapanART registry
Akira Kuwahara（Tokushima University）et al.

ISP―30― 4. A trial to predict blastocyst formation by the respiratory activity of humanembryos
Hiroki Kurosawa（Tohoku University）et al.

ISP―30― 5. Field Survey of Reproductive Medicine in Educational Establishments for Medical
Residency Programs in the Kanto Society of Obstetrics and Gynecology
Yuko Ikemoto（Juntendo University）et al.

13：40〜14：25

Group 31 Endometriosis
Moderator：Teikyo University Chiba Medical Center Toshio Igarashi!

!

ISP―31― 1. Effect of S100A6 over expression on β catenin in endometriosis
Zequn Liu
（Jiangxi Maternal and Child Health Hospital, China）et al.

!

!

ISP―31― 2. Increased secretion of monocyte chemoattractant protein 1（MCP 1）in!

endometriotic stroma cells is mediated by cell extracellular matrix adhesion andfocal adhesion kinase（FAK）!

Takashi Nagai（Nagoya University）et al.

ISP―31― 3. SR 16234, a selective estrogen receptor modulator, represses development of!

endometriosis like lesions in rat model
Fuminori Taniguchi（Tottori University）et al.

ISP―31― 4. Upregulation of versican in apparently normal peritoneum in women withendometriosis is not be secondary event but may be the cause
Hirohiko Tani（Kyoto University）et al.

!

!

ISP―31― 5. New diagnostic interface of endometriosis：NMS E（Numerical multi scoring
system of endometriosis）
Masao Ichikawa（Nippon Medical School）et al.

プログラム2016年 2 月

237（S―85）!

ISP―31― 6. Comparison of clinical efficacy of long term medical treatment with low dose oral
contraceptives or progestin in women with endometriosis
Michio Kitajima（Nagasaki University）et al.

ISP―31― 7. Enlarged uterine corpus volume in women with endometriosis：assessment using!

three dimensional reconstruction of pelvic magnetic resonance images!

Akemi Koshiba（Kyoto Prefectural University）et al.

ISP―31― 8. Involvement of Epithelial Mesenchymal Transition in Human Adenomyosis：roleof hepatocyte growth factor and estrogen
Khaleque Khan
（Kyoto Prefectural University）et al.

!

!

ISP―31― 9. Analgesic effects of levonorgestrel releasing intrauterine system（LNG IUS）on
patients with and without adenomyosis
Yasushi Hirota（The University of Tokyo）et al.

13：40〜14：25

Group 32 Endometriosis/Endometrium
Moderator：Oita University Kaei Nasu!

ISP―32― 1. Study using Anti Mullerian hormone（AMH）about the impact of laparoscopic
endometrial cystectomy on ovarian reserves
Masataka Ono（Tokyo Medical University）et al.

!

ISP―32― 2. Utility of assessment of presurgical serum anti Mullarian hormone values forprediction of poor ovarian responder after laparoscopic cystectomy for ovarian
endometrioma
Rie Ozaki（Juntendo University）et al.

ISP―32― 3. Hysterectomy does not change recurrence rate of ovarian endometrioma after
cystectomy
Hirofumi Haraguchi（The University of Tokyo）et al.

ISP―32― 4. Increased uterine artery vascular resistance on the endometrioma side in womenwith endometriosis!

Miyoko Waratani（Kyoto Prefectural University）et al.

ISP―32― 5. Anti inflammatory effects of drospirenone on endometriosis
Tomoko Makabe（The University of Tokyo）et al.

ISP―32― 6. The process of endometrial reconstruction in the mouse model of decellularized
matrix transplantation
Takehiro Hiraoka（The University of Tokyo）et al.

ISP―32― 7. Hypoxia inducible factor 2α（Hif2α）regulates embryo implantation
Leona Matsumoto（The University of Tokyo）et al.

ISP―32― 8. Leukemia inhibitory factor in the cervical epithelium is a possible biomarker ofuterine receptivity
Shota Igaue（The University of Tokyo）et al.

ISP―32― 9. Role of Versican V1 in an Embryo Implantation Model
Yumiko Miyazaki（Kyoto University）et al.

プ
ロ 22
グ日
ラ㈮
ム

プログラム238（S―86）

日産婦誌68巻 2 号

13：40〜14：25

Group 33 Fertility Preservation
Moderator：Saitama Medical University

プ
ロ 22
グ日
ラ㈮
ム

Yasushi Takai

ISP―33― 1. Infertility problems after abdominal radical trachelectomy
Kana Hiasa（Kyushu University）et al.

ISP―33― 2. Successful delivery after abdominal radical trachelectomy and in vitro
fertilization treated in the same facility throughout：a case report
Aya Takayama（Kyushu University）et al.

ISP―33― 3. Survey of attitudes toward uterus transplantation among Japanese women of
reproductive age
Kiyoko Umene（Keio University）et al.

ISP―33― 4. Fertility preservation in three AYA women with myelodysplastic syndrome
Noriko Nagata（Nagasaki University）et al.

ISP―33― 5. The oophorectomies conducted in this hospital for ovarian tissue cryopreservation
to avoid iatrogenic sterility in patients received treatment of malignant tumor
Yoko Tsuzuki（Juntendo University Urayasu Hospital）et al.

ISP―33― 6. Study on fertility preservation of young female patients suffering from collagendisease who had led to the administration of Cyclophosphamide
Eriko Shiraishi（The Jikei University）et al.

ISP―33― 7. Usefulness of the hypersensitive antimüllerian hormone（AMH）assay for detecting
very low AMH levels in association with menstrual status
Ken Shimizu（Nagoya University）et al.

ISP―33― 8. Serum antimullerian hormone in adolescents with PCOS!

Haritha Sagili（JIPMER, India）et al.

!

ISP―33― 9. Ovarian reserve after ultrasound guided high intensity focused ultrasound foruterine fibroids
Vincent Y.T. Cheung（Queen Mary Hospital, The University ofHong Kong, Hong Kong）

13：40〜14：15

Group 34 Infertility/Recurrent Pregnancy Loss
Moderator：Nagoya City University Yasuhiko Ozaki!

ISP―34― 1. A selective hysteroscopic hydro tubation is a useful item for tubal occlusion
therapy
Chie Oki（Kagoshima University）et al.

ISP―34― 2. What is the most effective indication for falloposcopic tuboplasty to achievepregnancy?
Kenji Sato
（Keio University）et al.

!

ISP―34― 3. Establishment of a mouse model for psychologically induced miscarriage
Takaaki Nagasaka（The University of Tokyo）et al.

プログラム2016年 2 月

239（S―87）

ISP―34― 4. Studies on the chromosomal abnormality in patients with recurrent abortion andthe prognosis of patients with inversion（9）of chromosome
Taro Nonaka（Niigata University）et al.

ISP―34― 5. Protein S deficiency complicated pregnancy in women with recurrent pregnancy
loss
Nanae Shinozaki（Kobe University）et al.

ISP―34― 6. Analysis from the nationwide data collection of preimplantation genetic diagnosis（PGD）outcome for recurrent pregnancy loss with translocation in Japan
Akira Nakabayashi（Keio University）et al.

!

ISP―34― 7. Treatment for patients with recurrent fetal losses positive for anti cardiolipin!

beta2 glycoprotein I antibody and/or lupus anticoagulant using Sairei to and low
dose aspirin
Yuko Yaginuma（Niigata University）et al.

13：40〜14：10

Group 35 Reproductive Endocrinology
Moderator：National Center for Child Health and Development Hidenori Akutsu
ISP―35― 1. The suppressive effect of immune stress on LH secretion is absent in the earlyneonatal period in rats
Munkhsaikhan Munkhzaya（Tokushima University）et al.

ISP―35― 2. Difference in myeloperoxidase between women with and without amenorrhea!

Takeo Shibata（Kanazawa Medical University）et al.

ISP―35― 3. PAI 1 in granulosa cells is suppressed directly by statin and indirectly by!

!

suppressing TGF β and TNF α in mononuclear cells by insulin sensitizing
drugs；a new therapy for PCOS
Osamu Yoshino（University of Toyama）et al.

ISP―35― 4. Role of CD59 in remodeling of the maternal spiral artery
Masashi Ueda（Kyoto University）et al.

ISP―35― 5. Perinatal effects of hormonal change on neuronal morphology and expression of
estrogen receptor α in the amygdala of female Wistar rats
Seiki Matsuo（Fukuchiyama City Hospital）et al.

!

ISP―35― 6. The expression of orexigenic and anorexigenic factors in middle aged female ratsthat had been subjected to prenatal undernutrition
Altankhuu Tungalagsuvd（Tokushima University）et al.

プ
ロ 22
グ日
ラ㈮
ム

プログラム240（S―88）

第2日

日産婦誌68巻 2 号

4 月 22 日（金） ポスター会場⑬
セミナー室（2）

プ
ロ 22
グ日
ラ㈮
ム

13：40〜14：35

Group 36 Womenʼs Health 1
Moderator：The University of Tokyo Osamu Hiraike!

ISP―36― 1. A case of a marked decrease in bone mineral density during long term
administration of Dienogest
Sayuri Nakanishi（Yokohama City University）et al.

!
!

ISP―36― 2. Effect of the dipeptidyl peptidase 4 inhibitor teneligliptin on glucose metabolism
in ovariectomized mice on a high fat diet
Azusa Sameshima（University of Toyama）et al.

!

ISP―36― 3. Palpitation in middle aged women is associated with anxiety
Masakazu Terauchi（Tokyo Medical and Dental University）et al.

!

ISP―36― 4. Modified Gilliam Doleris Uterine Suspension for Pelvic Organ Prolapse in a
Young Nullipara
Kentaro Kai（Oita University）et al.

ISP―36― 5. Obliterative LeFort colpocleisis for pelvic organ prolapse in elderly women aged
70 years and over!

Soo Cheen Ng（Chung Shan Medical University Hospital,
Taichung, Taiwan）et al.

ISP―36― 6. The role of physiotherapy in women with dysfunctional voiding presented as!

over activity bladder―A case report!

Yu Fen Lai（Comprehensive Pelvic Floor Health Care Center, Chung Shan
Medical University Hospital, Taichung, Taiwan）et al.

ISP―36― 7. Attitudes among Japanese Obstetrician/Gynecologists toward HPV vaccination,and the vaccination status of their daughters
Tomomi Takata（Osaka University）et al.

ISP―36― 8. Sharing family tree between midwife and genetics teamAkane Kondo（Shikoku Medical Center for Children and Adults）et al.

!

!

ISP―36― 9. A concept paper on human reproduction in inter generational inter stellar spacetravel―Recognising the obstetric and gynaecology issues and carcinogenesis!

Eugene WK Leong（MIS Gynae Surgeon, Taylorʼs University
School of Medicine, Kuala Lumpur, Malaysia）

ISP―36― 10. Effect of vaginal estriol treatment for total laparoscopic hysterectomy
Go Hirata（Yokohama City University Medical Center）et al.

ISP―36― 11. Foreign Body in Metrocolpos and Undesirable Consequences
Rana A（Tribhuvan University Teaching Hospital, Kathmandu, Nepal）et al.

プログラム2016年 2 月

241（S―89）

13：40〜14：35

Group 37 Womenʼs Health 2Moderator：Dokkyo Medical University Yoshiko Mochizuki
ISP―37― 1. Progressive direction of endometriosis evaluated by the density of follicles in thelesions of ovarian endometrioma
Takashi Mimura（Showa University）et al.

ISP―37― 2. A case report of multiple adenomyotic cysts derived from uterine serosa
Takafumi Kuroda（Hokkaido Obihiro Kyokai Hospital）et al.

!

ISP―37― 3. Follow up study of symptomatic submucous fibroids after hysteroscopic
myomectomy
Miho Ando（Iizuka Hospital）et al.

ISP―37― 4. Twisted adnexa―A Gynecological emergency and its laparoscopic manegement
Jyoti Chaubey（St. Judeʼs Hospital, Jhansi, India）et al.

ISP―37― 5. Laparoscopic creation of neovagina―Early experience from a developing country
Sanjay Chaubey（St. Judeʼs Hospital, Jhansi, India）et al.

ISP―37― 6. Surgical method of laparoscopic gonadectomy and histological examination for the
3 cases of AIS（Androgen Insensitivity Syndrome）
Mari Kitade（Juntendo University）et al.

ISP―37― 7. Laparoscopic diagnosis and treatment of 46, XY disorders of sex development
Hiroki Morita（Kobe University）et al.

ISP―37― 8. Ischemic heart disease and risk of perinatal factors
Naoshi Yamada（Miyazaki Medical Association Hospital）et al.

ISP―37― 9. Clinical Examinations on a delivery of placenta and its outcomes
Ayaka Nakashima（Senshu Regional Medical Center for Women and Children
Health；Rinku General Medical Center）et al.

ISP―37― 10. Challenges in providing maternity care in remote areas and islands for primarycare physicians in Japan：A qualitative study
Ayako Shibata（Yodogawa Christian Hospital）et al.

ISP―37― 11. The two cases of vaginoplasty and formation of new canal to vagina from uterine
body in women vaginal atresia with functional uterus
Kumiko Tanaka（Kyushu University Hospital）et al.

13：40〜14：15

Group 38 Reproduction/Perinatology
Moderator：Nihon University Tatsuo Yamamoto
ISP―38― 1. Neonatal outcomes after the implantation of human embryos vitrified using a!

closed system device
Hideyuki Iwahata（St. Marianna University）et al.

ISP―38― 2. Multiple steroidogenic pathways underlie androgen excess in polycystic ovary
syndrome
Kazuki Saito（National Center for Child Health and Development）et al.

プ
ロ 22
グ日
ラ㈮
ム

プログラム242（S―90）

日産婦誌68巻 2 号!

ISP―38― 3. Separated double embryo transfer（s DET）is a novel embryo transfer method toprevent multiple gestations in Assisted Reproductive Technology（ART）
treatment
Tomoya Hasegawa（Tokyo Medical University）et al.

プ
ロ 22
グ日
ラ㈮
ム

!

ISP―38― 4. The case that led to an emergency surgery to the pregnancy after IVF ET at theuterus inside and outside same time
Mari Hirano（Ehime Rosai Hospital）et al.

ISP―38― 5. Preformed Wolffian duct regulates Mullerian duct elongation independently of
canonical Wnt signaling or Lhx1 expression
Masahiko Chiga（Kumamoto University）et al.

ISP―38― 6. Platelet aggregation in citrated whole blood of the first trimester of pregnancy
Takeshi Umazume（Hokkaido University）et al.

ISP―38― 7. Prevention strategies in perinatal women with group B streptococcal infection
Yuki Ito（Nippon Medical School）et al.

14：15〜14：45

Group 39 Oncology
Moderator：Nagoya University Fumitaka Kikkawa
ISP―39― 8. An internet survey intended to find ways to improve the dismal cervical cancer
screening rate in young Japanese women
Satoshi Kubota（Osaka University）et al.

!

ISP―39― 9. Estrogen related receptor alpha promotes angiogenesis and proliferation inuterine endometrial cancer
Hiroshi Matsushima（Kyoto Prefectural University of Medicine）et al.

ISP―39― 10. Identification of microRNA as a biomarker in primary ovarian cancer
Satoshi Fukagawa（Fukuoka Medical University）et al.

ISP―39― 11. Efficacy of weekly paclitaxel and carboplatin for neoadjuvant chemotherapy ofepithelial ovarian cancer with poor condition patients
Hisamitsu Takaya（Kinki University）et al.

ISP―39― 12. A prospective study on the safety on chemotherapy combined with bevacizumabin Japanese patients with recurrent ovarian cancer
Yoshiko Nanki（Keio University）et al.

ISP―39― 13. The adequate distance of suture ligature in the laparoscopic surgery
Shin Takenaka（Showa University Fujigaoka Hospital）et al.

13：40〜14：00

Group 40 Oncology/Reproduction
Moderator：Wakayama Medical University

Kazuhiko Ino

ISP―40― 1. Accuracy and limitation of image diagnosis of lymph node metastasis in uterine
cervical cancer
Kosuke Murakami（Kinki University）et al.

プログラム2016年 2 月

243（S―91）

ISP―40― 2. Patientʼs characteristics and reproductive outcomes of radical trachelectomy!

Masumi Ishibashi（Tohoku University）et al.

ISP―40― 3. Expressions of TUBB3 and Bcl 2 effect paclitaxel sensitivity in ovarian cancer
cell
Ikue Ishikawa（Iwate Medical University）et al.

ISP―40― 4. Predictive factors for oocyte retrieval failure in controlled ovarian
hyperstimulation with GnRH agonist or antagonist protocols
Jun Matsukawa（Yamagata University）et al.

プ
ロ 22
グ日
ラ㈮
ム

プログラム244（S―92）

日産婦誌68巻 2 号

ミニワークショッププログラム
プ
ロ 22
グ日
ラ㈮
ム

第2日

4 月 22 日（金） 第 6 会場
ホール B5（2）14：50〜15：50

ミニワークショップ 1 早産管理と児の予後
座長：埼玉医科大学病院

亀井良政

日本医科大学多摩永山病院

中井

章人

MW1―

1. 多施設 炎症を伴わない単胎頸管長短縮症例に対する頸管縫縮術は有用か：多施設

MW1―

2.

妊婦の口腔内ケアが早産率にもたらす影響

MW1―

3.

幼若ラットへのデキサメタゾンまたはベタメタゾンの過量投与による成長後の学

MW1―

4.

共同ランダム化比較試験の結果より

大槻克文（日本早産予防研究会）他
吉田美帆（岩手県立中部病院）他

習・運動能力への影響

石田芽（大阪電気通信大）他! !

肺サーファクタントと胎脂は早産児の腸管を保護する〜胎児期における肺 皮膚 消化器間相互作用の解明を目指して〜

西島浩二（福井大）他

15：50〜16：35

ミニワークショップ 2 婦人科良性腫瘍全般

MW2―

1.

座長：東京女子医科大学

松井英雄

東邦大学医療センター大森病院

森田峰人

子宮筋腫によるエリスロポエチン産生とその腫瘍増大因子としての機能解析
浅野涼子（横浜市立大）他

MW2―

2.

閉経後に増大した子宮筋腫症例の臨床病理学的検討
吉田

MW2―

3.

胎盤ポリープ 24 例の検討

愛（神戸医療センター）他
空野すみれ（飯塚病院）他

16：35〜17：50

ミニワークショップ 3 子宮体部腫瘍
座長：東京慈恵医科大学附属第三病院

礒西成治

獨協医科大学

深澤

一雄

!

MW3―

1.

子宮内膜癌における palbociclib（PD 0332991）の機能解析

MW3―

2.

子宮体癌において miR 200a，miR 200b，
miR 429 は PTEN 遺伝子を標的としてい

MW3―

3.

!

!

!

る

米山剛一（日本医大）他

子宮体癌に対するメドロキシプロゲステロン＋メトホルミン併用妊孕性温存療法の臨床第 2 相試験

MW3―

4.

田中智人（大阪医大）他

三橋

暁（千葉大）他

子宮体癌 IIIC 期症例における完全郭清の重要性
高橋健太（国立がん研究センター中央病院）他

プログラム2016年 2 月

MW3―

5.

245（S―93）

レーザーマイクロダイセクションによって採取した単一患者の正常子宮内膜・異型増殖症，類内膜腺癌部分の全エクソンシーケンス

樋口正太郎（信州大）他

プ
ロ 22
グ日
ラ㈮
ム